Tasly Pharmaceutical Group Co. Ltd. (SHSE:600535) said it scraps plan to spin off BioPharm Unit for listing in Shanghai Star Market due to change in market environment.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.7 CNY | -1.37% | -4.53% | -19.51% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.51% | 2.83B | |
+38.97% | 6.09B | |
-22.28% | 4.14B | |
+3.48% | 3.23B | |
-7.29% | 2.39B | |
+42.43% | 1.9B | |
-4.71% | 1.57B | |
-15.15% | 1.55B | |
-14.86% | 1.5B | |
+38.27% | 1.43B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Tasly Pharmaceutical Group Scraps Plan to Spin Off BioPharm Unit for Listing